stella
beta
Efficacy and Safety of the CG-100 Intraluminal Bypass Device — Stella
Home
/
Rectal Cancer
/
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
View on ClinicalTrials.gov
Recruiting
Back to Rectal Cancer trials
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(14 sites)
United States
University of California Irvine, Orange, California
Kaiser Permanente San Diego medical Center, San Diego, California
Colorado University Anschutz Medical Campus, Aurora, Colorado
University of Louisville, Louisville, Kentucky
Henry Ford Health System, Detroit, Michigan
East Bank Hospital - M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota
New York-Presbyterian / Weill Cornell Medical Center, New York, New York
Jefferson University Hospital, Philadelphia, Pennsylvania
Lifespan & Brown Surgical Associates, Providence, Rhode Island
University of Utah Health, Salt Lake City, Utah
Israel
Soroka University Medical Center, Beersheba
Carmel Medical Center, Haifa
Rabin Medical Center, Petah Tikva
Italy
Humanitas Research Hospital, Milan, Lombardy